Researchers have suggested that complement C3 is activated in podocytes and renal tubules in animal models of diabetic nephropathy, causing fibrosis and renal dysfunction, and that administration of C3 receptor blockers protects diabetic nephropathy podocytes from injury [72,73]. The gene discussed is C3; the disease is diabetic kidney disease.